Skip to main content
logo
Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.5949
-0.0517 (-8.00%)
At close: Jul 13, 2026, 4:00 PM EDT
0.5612
-0.0337 (-5.66%)
After-hours: Jul 13, 2026, 7:53 PM EDT

Lexaria Bioscience Cash Flow Statement

Millions USD. Fiscal year is Sep - Aug.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Net Income
-7.74-11.91-5.81-6.71-7.38-4.19
Depreciation & Amortization
0.080.090.080.150.10.11
Stock-Based Compensation
0.370.860.490.171.951.28
Other Adjustments
0.280.320.170.370.8-1.26
Change in Receivables
0.31-0.21-0.040.03-0.140.19
Changes in Inventories
---0.04-00.1
Changes in Accounts Payable
-1.110.40.830.090.050.01
Changes in Unearned Revenue
0-00---0.04
Changes in Other Operating Activities
0.390.02-0.69-0.01-0.26-0.19
Operating Cash Flow
-7.43-10.45-4.96-5.88-4.88-3.99
Capital Expenditures
-0.04-0.02-0.04-0.03-0.05-
Sale of Property, Plant & Equipment
-----0.27
Purchases of Intangible Assets
-0.06-0.08-0.15-0.14-0.13-0.08
Purchases of Investments
-0.07-0.14----
Investing Cash Flow
-0.24-0.24-0.19-0.17-0.180.19
Long-Term Debt Issued
------0.02
Net Long-Term Debt Issued (Repaid)
------0.02
Issuance of Common Stock
6.526.0510.321.59-13.49
Net Common Stock Issued (Repurchased)
6.526.0510.321.59-13.49
Other Financing Activities
-----0.04-0.04
Financing Cash Flow
9.786.0510.321.59-0.0413.42
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.03-0.05-0.02---
Net Cash Flow
-1.12-4.75.15-4.46-5.19.62
Free Cash Flow
-7.47-10.48-5-5.91-4.93-3.99
FCF Margin
-3848.61%-1483.88%-1077.38%-2614.84%-1929.75%-552.02%
Free Cash Flow Per Share
-0.33-0.58-0.40-0.89-0.84-0.91
Levered Free Cash Flow
-8.42-11.43-5.62-6.44-7.43-4.06
Unlevered Free Cash Flow
-8.39-11.41-5.58-6.31-6.78-5.7
SEC Filings: 10-K · 10-Q